WEST LAFAYETTE, Ind. (PRWEB)October 15, 2021 Starting Monday, October 18th, Dr. Susan-Bogdanowich-Knipp, President of Ravine Pharmaceuticals and consultant with Improved Pharma, will present “Polymorph Screen of Newly Discovered Salts of Bedaquiline”. The poster (M2142) Read more
WEST LAFAYETTE, Ind. (PRWEB)October 11, 2021 Improved Pharma is pleased to announce a new collaboration with Stephan Parent of Solsta Consulting, LLC. Stephan Parent has more than two decades of solid-state chemistry experience in Read more
WEST LAFAYETTE, Ind. (PRWEB)October 06, 2021 Improved Pharma is pleased to announce expanded capabilities with the new addition of an in-house Coulometric Karl Fischer titrator equipped with a Stromboli oven sample changer. Understanding the Read more
Improved Pharma is pleased to announce the addition of Ruba Alajlouni to the team. Ruba brings expertise in regulatory and quality compliance along with hands-on experience in microbiology, cell culture, molecular biology, protein purification, Read more
Improved Pharma is pleased to announce an additional open-source publication describing the structures of Bedaquiline maleate salts that is now available to download. Previously, our lab was able to identify promising new benzoate salts of Read more
WEST LAFAYETTE, IND. (PRWEB) APRIL 26, 2021 Improved Pharma is delighted to announce the expansion of its current laboratory to accommodate additional research capabilities. The addition of the newly acquired laboratory facility in the Purdue Read more
Dr, Stephen Byrn, CSO of Improved Pharma, was a key contributor to a recent publication describing the usefulness of mini-tablets in monitoring the dose-response of lapatinib solid amorphous dispersions in juvenile pigs. Juvenile pigs have been well-established Read more
A recent collaboration with our colleagues further advances the field of X-ray pair distribution function analysis applied to the analysis of amorphous solid dispersions. In this paper, we present the results of different polymer:flubendazole Read more
In February 2021, the FDA issued a guidance aimed at preventing unacceptable levels of nitrosamine impurities in pharmaceutical products. This guidance required a risk assessment to be completed by March 31, 2021. This is Read more
Improved Pharma is pleased to announce the open-source publication of research into finding new salts of bedaquiline, an important drug for the treatment of tuberculosis. The drug is currently marketed in the US as Read more
